Regulatory Actions of the Week
Comment on OMBs Draft Memorandum to the Heads of Executive Departments and Agencies, Guidance for Regulation of Artificial Intelligence Applications
Comment on National Strategy for Mapping, Exploring, and Characterizing the U.S. EEZ
FDA Amends Biological Product Definition and Defines the Statutory Term Protein
COMMENT ON NEW CHANGES TO EPA’S PROPOSED RULES STRENGTHING TRANSPARENCY IN REGULATORY SCIENCE
Who Gets a Ventilator in a Time of Scarcity?
FDA Sends OMB an ICR Governing FDA’s Administrative Practices and Procedures